South San Francisco, CA
Alector, Inc. operates as a clinical stage biopharmaceutical company. The Company researches and develops novel therapeutics for the treatment of neurodegeneration and other brain disorders. Alector offers its services in the State of California.
alector.comThese are collections Alector is a part of. Click on the collection name to view similar companies.
Post Ipo Debt
$50,000,000
Post Ipo Equity
$75,000,000
IPO
Unknown
Series E
$133,000,000
Series D
$29,500,000
Series C
$32,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Alector.